Back to Search
Start Over
Chemerin-9 is neuroprotective in APP/PS1 transgenic mice by inhibiting NLRP3 inflammasome and promoting microglial clearance of Aβ.
- Source :
-
Journal of neuroinflammation [J Neuroinflammation] 2025 Jan 08; Vol. 22 (1), pp. 5. Date of Electronic Publication: 2025 Jan 08. - Publication Year :
- 2025
-
Abstract
- Background: Alzheimer's disease (AD) is a prevalent neurodegenerative disorder worldwide, and microglia are thought to play a central role in neuroinflammatory events occurring in AD. Chemerin, an adipokine, has been implicated in inflammatory diseases and central nervous system disorders, yet its precise function on microglial response in AD remains unknown.<br />Methods: The APP/PS1 mice were treated with different dosages of chemerin-9 (30 and 60 µg/kg), a bioactive nonapeptide derived from chemerin, every other day for 8 weeks consecutively. The primary mouse microglia were stimulated by amyloid beta 42 (Aβ <subscript>42</subscript> ) oligomers followed by treatment with chemerin-9 in vitro. ChemR23 inhibitor α-NETA was further used to investigate whether the effects of chemerin-9 were ChemR23-dependent.<br />Results: We found that the expression of chemerin and ChemR23 was increased in AD. Intriguingly, treatment with chemerin-9 significantly ameliorated Aβ deposition and cognitive impairment of the APP/PS1 mice, with decreased microglial proinflammatory activity and increased phagocytic activity. Similarly, chemerin-9-treated primary microglia showed increased phagocytic ability and decreased NLRP3 inflammasome activation. However, the ChemR23 inhibitor α-NETA abolished the neuroprotective microglial response of chemerin-9.<br />Conclusions: Collectively, our data demonstrate that chemerin-9 ameliorates cognitive deficits in APP/PS1 transgenic mice by boosting a neuroprotective microglial phenotype.<br />Competing Interests: Declarations. Ethics approval and consent to participate: All procedures were authorized by the ethical committee on animal welfare of Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine. Consent for publication: All of the authors approved the final version for publication. Competing interests: The authors declare no competing interests.<br /> (© 2025. The Author(s).)
- Subjects :
- Animals
Mice
Humans
Neuroprotective Agents pharmacology
Neuroprotective Agents therapeutic use
Intercellular Signaling Peptides and Proteins metabolism
Intercellular Signaling Peptides and Proteins genetics
Mice, Inbred C57BL
Chemokines metabolism
Cells, Cultured
Male
Mice, Transgenic
Microglia drug effects
Microglia metabolism
NLR Family, Pyrin Domain-Containing 3 Protein metabolism
NLR Family, Pyrin Domain-Containing 3 Protein antagonists & inhibitors
Amyloid beta-Peptides metabolism
Presenilin-1 genetics
Inflammasomes metabolism
Amyloid beta-Protein Precursor genetics
Amyloid beta-Protein Precursor metabolism
Alzheimer Disease metabolism
Alzheimer Disease drug therapy
Alzheimer Disease pathology
Subjects
Details
- Language :
- English
- ISSN :
- 1742-2094
- Volume :
- 22
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Journal of neuroinflammation
- Publication Type :
- Academic Journal
- Accession number :
- 39780188
- Full Text :
- https://doi.org/10.1186/s12974-024-03325-y